| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $16.5B | $18.4B | $18.3B | $19.9B | $21.3B | $22.6B | $23.7B | $26.8B |
| Distributions in excess of accumulated earnings | $2.5B | $2.5B | $2.5B | $2.6B | $2.6B | $2.6B | $2.6B | $2.7B |
| Additional paid-in capital | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B |
| Additional paid-in capital | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B |
| Retained earnings | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M |
| Preferred stock | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M | $66.9M |
| Accumulated other comprehensive income (loss) | -$47.3M | -$39.4M | -$43.1M | -$39.3M | -$39.1M | -$35.7M | -$31.7M | -$31.4M |
| Common stock | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.2M | $1.3M |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.2M | $1.3M |